Arcus Biosciences, Inc. (RCUS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcus Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.176 Hello, everyone. Thank you for joining us and welcome to the Arcus Biosciences 00:00:05.176 -- 00:00:09.720 first quarter 2026 business updates and financial results. 00:00:09.720 -- 00:00:13.984 After today's prepared remarks, we will host a question and answer session. 00:00:13.984 -- 00:00:17.547 Please limit yourself to one question and one follow up. 00:00:17.547 -- 00:00:22.671 If you would like to ask a question, please press star one to raise your hand. 00:00:22.671 -- 00:00:26.475 To withdraw your question, press star one again. 00:00:26.475 -- 00:00:30.018 I will now hand the conference over to Holly Kolke. 00:00:30.018 -- 00:00:35.086 VP of Corporate Affairs. Holly, please go ahead. 00:00:35.086 -- 00:00:39.693 Good afternoon, and thank you for joining us on today's conference call to discuss Arcasys' 00:00:39.693 -- 00:00:44.440 first quarter 2026 financial results and pipeline updates. 00:00:44.440 -- 00:00:48.726 I'd like to remind you that on this call, management will make forward-looking statements, 00:00:48.726 -- 00:00:53.954 including statements about our development strategies and our expectations regarding 00:00:53.954 -- 00:00:59.026 the advantages and opportunities afforded by our investigational products, 00:00:59.026 -- 00:01:03.853 our clinical development milestones and timelines, our projected cash runway, and our 00:01:03.853 -- 00:01:09.041 financial outlook. All statements other than historical facts reflect the current 00:01:09.041 -- 00:01:14.068 beliefs and expectations of management and involve risks and uncertainties that may 00:01:14.068 -- 00:01:18.174 cause our actual results to differ from those expressed. 00:01:18.174 -- 00:01:23.382 Those risks and uncertainties are described in our most r...